Literature DB >> 8605944

Activated B cells express functional Fas ligand.

M Hahne1, T Renno, M Schroeter, M Irmler, L French, T Bornard, H R MacDonald, J Tschopp.   

Abstract

Fas ligand (FasL, Apo-1L) is a member of the tumor necrosis factor protein family and binding to its receptor (Fas, Apo-1, CD95) triggers cell death through apoptosis. Ligand expression is restricted to cells with known cytolytic activity and found on hematopoietic cells of the T cell and natural killer lineage. Here we provide evidence that B lymphocytes can express FasL. Flow cytometric analysis revealed that FasL is expressed on the surface of B cells upon stimulation with either lipopolysaccharide or phorbol 12-myristate 13-acetate/ionomycin. FasL expression on activated B cells was confirmed by western blot and reverse transcriptase polymerase chain reaction analysis. FasL on B cells is functional since lipopolysaccharide-activated B lymphocytes derived from wild type, but not from gld mutant mice, were able to kill Fas-sensitive target cells. Our data suggest that the Fas system may contribute to the control of B cell homeostasis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8605944     DOI: 10.1002/eji.1830260332

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  48 in total

1.  Soluble Fas-ligand (sFasL) in human astrocytoma cyst fluid is cytotoxic to T-cells: another potential means of immune evasion.

Authors:  B Frankel; S L Longo; G W Canute
Journal:  J Neurooncol       Date:  2000-05       Impact factor: 4.130

2.  Modulation of CD4+ T-cell activation by CD95 co-stimulation.

Authors:  M Paulsen; S Valentin; B Mathew; S Adam-Klages; U Bertsch; I Lavrik; P H Krammer; D Kabelitz; O Janssen
Journal:  Cell Death Differ       Date:  2010-11-05       Impact factor: 15.828

Review 3.  Killer B lymphocytes: the evidence and the potential.

Authors:  Steven K Lundy
Journal:  Inflamm Res       Date:  2009-03-05       Impact factor: 4.575

4.  B cells from aged mice exhibit reduced apoptosis upon B-cell antigen receptor stimulation and differential ability to up-regulate survival signals.

Authors:  C L Montes; B A Maletto; E V Acosta Rodriguez; A Gruppi; M C Pistoresi-Palencia
Journal:  Clin Exp Immunol       Date:  2006-01       Impact factor: 4.330

Review 5.  The Fas counterattack: a molecular mechanism of tumor immune privilege.

Authors:  J O'Connell; M W Bennett; G C O'Sullivan; J K Collins; F Shanahan
Journal:  Mol Med       Date:  1997-05       Impact factor: 6.354

6.  Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.

Authors:  H Tighe; K Warnatz; D Brinson; M Corr; W O Weigle; S M Baird; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

7.  Coxiella burnetii Avirulent Nine Mile Phase II Induces Caspase-1-Dependent Pyroptosis in Murine Peritoneal B1a B Cells.

Authors:  Laura Schoenlaub; Rama Cherla; Yan Zhang; Guoquan Zhang
Journal:  Infect Immun       Date:  2016-11-18       Impact factor: 3.441

8.  A novel function of B lymphocytes from normal mice to suppress autoimmunity in (NZB x NZW)F1 mice.

Authors:  S Ono; D Shao; S Yamada; Y Yang; M Yamashita; T Hamaoka
Journal:  Immunology       Date:  2000-05       Impact factor: 7.397

9.  FasL and FADD delivery by a glioma-specific and cell cycle-dependent HSV-1 amplicon virus enhanced apoptosis in primary human brain tumors.

Authors:  Ivy A Ho; Wai H Ng; Paula Y Lam
Journal:  Mol Cancer       Date:  2010-10-13       Impact factor: 27.401

10.  Innate pro-B-cell progenitors protect against type 1 diabetes by regulating autoimmune effector T cells.

Authors:  Ruddy Montandon; Sarantis Korniotis; Esther Layseca-Espinosa; Christophe Gras; Jérôme Mégret; Sophie Ezine; Michel Dy; Flora Zavala
Journal:  Proc Natl Acad Sci U S A       Date:  2013-05-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.